187 related articles for article (PubMed ID: 18612193)
1. Infective endocarditis after alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
Zemanek D; Veselka J; Chmelova R
Int Heart J; 2008 May; 49(3):371-5. PubMed ID: 18612193
[TBL] [Abstract][Full Text] [Related]
2. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies.
Alam M; Dokainish H; Lakkis N
J Interv Cardiol; 2006 Aug; 19(4):319-27. PubMed ID: 16881978
[TBL] [Abstract][Full Text] [Related]
3. Post-transcoronary ethanol septal ablation (TESA) infective endocarditis complicated by a ventricular septal defect.
Liang M; Pasupati S; Jogia D
J Invasive Cardiol; 2011 Aug; 23(8):348-50. PubMed ID: 21828402
[TBL] [Abstract][Full Text] [Related]
4. Successful percutaneous transluminal septal myocardial ablation through a right superior septal artery for a patient with hypertrophic obstructive cardiomyopathy.
Kurita T; Tsuchikane E; Tanaka N; Suzuki T
Cardiovasc Interv Ther; 2015 Oct; 30(4):377-81. PubMed ID: 25502014
[TBL] [Abstract][Full Text] [Related]
5. Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy: A propensity score-matched cohort.
Nguyen A; Schaff HV; Hang D; Nishimura RA; Geske JB; Dearani JA; Lahr BD; Ommen SR
J Thorac Cardiovasc Surg; 2019 Jan; 157(1):306-315.e3. PubMed ID: 30279000
[TBL] [Abstract][Full Text] [Related]
6. Concomitant ablation for atrial fibrillation during septal myectomy in patients with hypertrophic obstructive cardiomyopathy.
Bogachev-Prokophiev AV; Afanasyev AV; Zheleznev SI; Pivkin AN; Fomenko MS; Sharifulin RM; Karaskov AM
J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1536-1542.e2. PubMed ID: 28947201
[TBL] [Abstract][Full Text] [Related]
7. [Alcohol ablation of the interventricular septum in a patient with hypertrophic obstructive cardiomyopathy complicated by an increase in the pressure gradient in the left ventricular outflow tract. A case report].
Płazak W; Podolec P; Krochin M; Gackowski A; Pieniazek P; Kapelak B; Sadowski J; Tracz W
Kardiol Pol; 2006 Sep; 64(9):989-93. PubMed ID: 17054031
[TBL] [Abstract][Full Text] [Related]
8. Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: Transcoronary and Endocardial Approach.
Aksu T; Guler T; Yalin K; Golcuk SE; Ozcan K
Am J Med Sci; 2016 Nov; 352(5):466-471. PubMed ID: 27865293
[TBL] [Abstract][Full Text] [Related]
9. Descending septal branch of right coronary artery: Rare, but important in hypertrophic cardiomyopathy.
Chatterjee A; Oates ET; Leesar MA; Alli OO
Cardiovasc Revasc Med; 2017 Sep; 18(6S1):23-25. PubMed ID: 28365416
[TBL] [Abstract][Full Text] [Related]
10. Pressure gradient response after alcohol septal ablation in hypertrophic obstructive cardiomyopathy.
Veselka J
Kardiol Pol; 2006 Oct; 64(10):1161-2; author reply 1162. PubMed ID: 17214026
[No Abstract] [Full Text] [Related]
11. Transcatheter alcohol ablation of the septum in a patient of hypertrophic obstructive cardiomyopathy.
Bhargava B; Agarwal R; Kaul U; Manchanda SC; Wasir HS
Cathet Cardiovasc Diagn; 1997 May; 41(1):56-8. PubMed ID: 9143769
[TBL] [Abstract][Full Text] [Related]
12. Surgical management of obstructive hypertrophic cardiomyopathy: the gold standard.
Brown ML; Schaff HV
Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):715-22. PubMed ID: 18510487
[TBL] [Abstract][Full Text] [Related]
13. Alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
Nielsen CD; Fernandes V; Spencer WH
Am Heart Hosp J; 2003; 1(1):83-90. PubMed ID: 15785181
[TBL] [Abstract][Full Text] [Related]
14. [Clinical case of the month. Treatment of obstructive hypertrophic cardiomyopathy by percutaneous septal ablation].
Hoffer E; Boland J
Rev Med Liege; 2002 Jul; 57(7):433-7. PubMed ID: 12233217
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous septal ablation for left mid-ventricular obstructive hypertrophic cardiomyopathy: a case report.
Tengiz I; Ercan E; Alioglu E; Turk UO
BMC Cardiovasc Disord; 2006 Apr; 6():15. PubMed ID: 16606458
[TBL] [Abstract][Full Text] [Related]
16. Radiofrequency septal reduction in symptomatic hypertrophic obstructive cardiomyopathy.
Crossen K; Jones M; Erikson C
Heart Rhythm; 2016 Sep; 13(9):1885-90. PubMed ID: 27132152
[TBL] [Abstract][Full Text] [Related]
17. Changes in the left ventricular outflow tract after transcoronary ablation of septal hypertrophy (TASH) for hypertrophic obstructive cardiomyopathy as assessed by transoesophageal echocardiography and by measuring myocardial glucose utilization and perfusion.
Kuhn H; Gietzen FH; Schäfers M; Freick M; Gockel B; Strunk-Müller C; Jachmann E; Schober O
Eur Heart J; 1999 Dec; 20(24):1808-17. PubMed ID: 10581139
[TBL] [Abstract][Full Text] [Related]
18. Endocardial septal ablation for hypertrophic obstructive cardiomyopathy.
Aksu T; Güler TE; Yalın K; Gölcük ŞE; Özcan KS
Turk Kardiyol Dern Ars; 2017 Jan; 45(1):67-72. PubMed ID: 28106021
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of alcohol septal ablation in patients with symptomatic concentric left ventricular hypertrophy and outflow tract obstruction.
Kovacic JC; Khanna D; Kaplish D; Karajgikar R; Sharma SK; Kini A
J Invasive Cardiol; 2010 Dec; 22(12):586-91. PubMed ID: 21127363
[TBL] [Abstract][Full Text] [Related]
20. Surgical septal myectomy versus septal alcohol ablation for hypertrophic obstructive cardiomyopathy.
Efthimiadis GK; Meditskou S; Vassilikos V; Hadjimiltiades S; Styliadis IH; Parcharidis GE
Swiss Med Wkly; 2008 May; 138(21-22):322; author reply 322-3. PubMed ID: 18578089
[No Abstract] [Full Text] [Related]
[Next] [New Search]
